Cardiovascular Disease

Cardiovascular disease (CVD) is the leading cause of death in the United States and disproportionately affects African Americans. For some people, taking a daily dose of aspirin is an effective, low cost option for preventing heart attacks and strokes. A new study from the University of Minnesota School of Public Health; so recently publish in the Journal of Community Health, detail the use of aspirin for CVD prevention in African Americans and found that positive cultural beliefs around taking it make people more likely to adopt the intervention.

Aspirin for Cardiovascular Disease

This study sought to describe the use of aspirin for CVD prevention in African Americans; also evaluate associations with demographics, cardiovascular risk factors and health behaviors and beliefs. A total of 684 African Americans adults ages 45-79 years complete surveys and were include in this analysis.

The study was led by Jeremy Van’t Hof, an M.S. student and physician; also co-author by Professor Russell Luepker, who leads the “Ask About Aspirin” campaign in Minnesota. The campaign encourages patients to ask their providers if taking a daily aspirin is a safe; so effective way to help them avoid heart attacks or strokes.

To learn more about aspirin use among African Americans; so the researchers survey 684 adults ages 45-79 in community settings, including churches, health fairs and gyms. The adults were ask questions regarding their demographics; also aspirin use, health behaviors and beliefs, as well as if they’d ever had a heart attack or stroke.

Risk factors a respondent

The study found: high risk factors for CVD, such as hypertension; so they were common in people who hadn’t yet suffer a heart attack or stroke; the more risk factors a respondent had; so the more likely they were to be taking aspirin; respondents whose peers thought they should be taking aspirin were seven times more likely to do so.

People whose peers were taking aspirin were five times more likely to use it themselves; adults who had a discussion about aspirin use with their provider were six times more likely to be taking it. The findings show that if the social environment around a prevention approach is positive; so then people are much more likely to do it, says Van’t Hof.

It might also mean that a clinic isn’t always; so the best location to reach people and change their behavior. People may feel a greater sense of accountability and more social support in community settings. Van’t Hof is considering continuing the research by repeating the survey so that he can track CVD risk factors in African Americans; also see how their aspirin use plays out over time.